← Insider buys
EWTX

Edgewise Therapeutics, Inc. · Healthcare

Orbimed Advisors LLC bought $10.0M of Edgewise Therapeutics, Inc.

Director and 10% owner

Bought$10,000,000
$20.13Price
496,771Shares
−938%Stake

What EWTX did for a copier

Filed Apr 4Copier in Apr 7
$1,000 copied at Mon, Apr 7 open, $11.66
$1,275
S&P 500, same days
+21.2%

Measured over 30 trading days, to the May 20 close.

Orbimed Advisors LLC's record

34 other buys with 3 months of prices since 2016: on average −12.7% against the S&P 500, and 12 of 34 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Thu, Apr 3. Filed Fri, Apr 4, 7:33 PM ET, after the close. Returns use the Apr 7 open and the May 20 close. Not investment advice.